Microfluidic Liquid Biopsy Minimally Invasive Cancer Diagnosis by Nano-Plasmonic Label-Free Detection of Extracellular Vesicles: Review
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136352 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Keshava Praveena Neriya Hegade und 2 weiteren Autor:innen. Beteiligte Einrichtung: Optical Bio-Microsystems Laboratory, Department of Mechanical and Industrial Engineering, Concordia University, Montreal, QC H3G 1M8, Canada. Hauptthemen laut MEDLINE: Extracellular Vesicles, Neoplasms, Microfluidics. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: M. Packirisamy’s NSERC and CuRC research grants, R.B. Bhat’s NSERC grant.
Abstract (Originalsprache)
Cancer diagnosis requires alternative techniques that allow for early, non-invasive, or minimally invasive identification. Traditional methods, like tissue biopsies, are highly invasive and can be traumatic for patients. Liquid biopsy, a less invasive option, detects cancer biomarkers in body fluids such as blood and urine. However, early-stage cancer often presents low biomarker levels, making sensitivity a challenge for integrating liquid biopsy into early diagnosis. Recent studies revealed that extracellular vesicles (EVs) secreted by cells are apt markers for liquid biopsy. Detecting extracellular vesicles (EVs) for liquid biopsy faces challenges like low sensitivity, EV subtype heterogeneity, and difficulty isolating pure populations. Label-free methods, such as plasmonic biosensors and Raman spectroscopy, offer potential solutions by enabling direct analysis without markers, improving accuracy, and reducing complexity. This review paper discusses current challenges in EV-based liquid biopsy for cancer diagnosis and prognosis. It addresses the effective use of microfluidics and nano-plasmonic approaches to address these challenges. Enhancing label-free EV detection in liquid biopsy could revolutionize early cancer diagnosis by offering non-invasive, cost-effective, and rapid testing. This could improve patient outcomes through personalized treatment and ease the burden on healthcare systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Optical Bio-Microsystems Laboratory, Department of Mechanical and Industrial Engineering, Concordia University, Montreal, QC H3G 1M8, Canada.
ORCID-Profile: Keshava Praveena Neriya Hegade, Muthukumaran Packirisamy
Förderung
- M. Packirisamy’s NSERC and CuRC research grants
- R.B. Bhat’s NSERC grant
Zitieren
APA
Neriya Hegade, K. P., Bhat, R. B., & Packirisamy, M. (2025). Microfluidic Liquid Biopsy Minimally Invasive Cancer Diagnosis by Nano-Plasmonic Label-Free Detection of Extracellular Vesicles: Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136352
Vancouver
Neriya Hegade KP, Bhat RB, Packirisamy M. Microfluidic Liquid Biopsy Minimally Invasive Cancer Diagnosis by Nano-Plasmonic Label-Free Detection of Extracellular Vesicles: Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136352
BibTeX
@article{NeriyaHegade2025,
author = {Neriya Hegade, Keshava Praveena and Bhat, Rama B and Packirisamy, Muthukumaran},
title = {Microfluidic Liquid Biopsy Minimally Invasive Cancer Diagnosis by Nano-Plasmonic Label-Free Detection of Extracellular Vesicles: Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136352}
}
EUVIMED